Acceptance of HIV-1 antibody testing methods, access and prices in different populations
| Questions | Classification | Population(n (%)) | χ2 | P value | ||||
| STUs | PW | Subjects undergoing VCT | Persons with IDU | FSWs | ||||
| Reagent types | Blood | 781 (78.1) | 599 (59.9) | 85 (85.0) | 74 (24.3) | 88 (43.6) | 430.498 | <0.001 |
| Saliva | 72 (7.2) | 45 (4.5) | 6 (6.0) | 13 (4.3) | 6 (3.0) | |||
| Urine | 147 (14.7) | 356 (35.6) | 9 (9.0) | 217 (71.4) | 108 (53.5) | |||
| Purchase channels | Pharmacy | 382 (38.2) | 202 (20.2) | 26 (26.0) | 176 (57.9) | 107(53) | 494.970 | <0.001 |
| Online shopping | 38 (3.8) | 42 (4.2) | 24 (24.0) | 66 (21.7) | 9 (4.5) | |||
| Medical institution | 565 (56.5) | 725 (72.5) | 45 (45.0) | 39 (12.8) | 85 (42.1) | |||
| Vending machine | 15 (1.5) | 31 (3.1) | 5 (5.0) | 23 (7.6) | 1 (0.5) | |||
| Acceptable price (US$) | <4.35 | 537 (53.7) | 575 (57.5) | 20 (20.0) | 222 (73.0) | 99 (49.0) | 152.710 | <0.001 |
| 4.35–8.69 | 285 (28.5) | 252 (25.2) | 39 (39.0) | 63 (20.7) | 86 (42.6) | |||
| 8.70–17.39 | 117 (11.7) | 128 (12.8) | 23 (23.0) | 17 (5.6) | 16 (7.9) | |||
| ≥17.40 | 61 (6.1) | 45 (4.5) | 18 (18.0) | 2 (0.7) | 1 (0.5) | |||
| Willingness to self-test | Yes | 762 (76.2) | 451 (45.1) | 83 (83.0) | 143 (47.0) | 106 (52.5) | 245.966 | <0.001 |
| No | 238 (23.8) | 549 (54.9) | 17 (17.0) | 161 (53.0) | 96 (47.5) | |||
FSWs, female sex workers; IDU, injection drug use; PW, pregnant women; STUs, students enrolled in tertiary institutions; VCT, voluntary HIV counselling and testing.